On Oct. 4, 2024, Exact Sciences announced the U.S. Food and Drug Administration (FDA) had approved the Cologuard…
On Oct. 4, 2024, the Centers for Disease Control and Prevention (CDC) published data that showed older adults…
On Oct. 3, 2024, scientists announced the largest whole-exome sequencing study of epilepsy to date, with more than…
On Oct. 3, 2024, the California Department of Public Health (CDPH) reported that the human case previously under…
On Oct. 3, 2024,the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP)…
On Oct. 3, 2024, the World Health Organization (WHO) announced it had listed the first mpox in vitro…
On Oct. 3, 2024, the Nebraska Department of Health and Human Services announced that 18 cases of tularemia…
On Oct. 2, 2024, the World Health Organization (WHO) announced it had been notified of one human case…
On Oct. 2, 2024, Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine…
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
On Oct. 1, 2024, a study by the University of Amsterdam and the Trimbos Institute showed that 20%…
On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….
On Sept. 30, 2024, a research team reported that emerging evidence suggested that mild cognitive impairment, which is…
On Sept. 30, 2024, a University College London research team announced technology that can deliver photoacoustic tomography (PAT)…
On Sept. 28, 2024, the World Health Organization (WHO) announced that Rwandan health authorities were intensifying outbreak control…
On Sept. 27, 2024, a study that evaluated the structural and functional connectivity correlates of fatigue in post-COVID…
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
On Sept. 26, 2024, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers Squibb’s Cobenfy (xanomeline and trospium…
On Sept. 24, 2024, the Mark O. Hatfield Clinical Research Center at the National Institutes of Health (NIH)…
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
On Sept. 23, 2024, researchers from the Wellcome Sanger Institute and their collaborators at GeneDx, announced results of…
On Sept. 23, 2024, researchers from Columbia University reported that a study of Children born during the first…
On Sept. 20, 2024, a research team led by scientists at the University of California, Riverside, announced they…
On Sept. 19, 2024, Oxitec announced it had launched Sparks™, a new commercial platform to accelerate the global…
On Sept. 19, 2024, the nonprofit organization Focus on Lyme and Aces Diagnostics announced a breakthrough in Lyme…
On Sept. 19, 2024, a U.S. population-based birth cohort study was released that showed that 53.4% of babies…
On Sept. 19, 2024, an international team of researchers announced a study that genetically traced the epicenter of…
On Sept. 18, 2024, a study published in The Lancel reported that here has been a rapid rise…
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…